Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us

Profile

Dr. Meagan Deming

MD

Meagan Deming

University of Maryland School of Medicine, Baltimore MD, USA

Dr. Meagan Deming is a board-certified Infectious Disease specialist with a primary research interest in respiratory viruses, including coronaviruses and influenza. She earned her MD & PhD at the University of North Carolina studying SARS-coronavirus vaccine strategies and antibody neutralization. She has served as a covering physician for COVID-19 vaccine and therapeutic clinical trials, including helping to lead the ‘Mix and Match’ trial studying delayed heterologous SARS-CoV-2 vaccines. Currently an assistant professor at the University of Maryland Center for Vaccine Development and Global Health, she is an active investigator in the CIVICs network, working on an influenza challenge study as well as influenza vaccine clinical trials, and is PI for the 'SNIFF study' exploring asymptomatic SARS-CoV-2 infections after vaccination.